Beyond-use date (revision 21)
Old revision·03:14, 9 Jan 2025·Retention_Time_Rae
| Beyond-use date | |
|---|---|
A beyond-use date is assigned by the person who prepares or opens a preparation, and is recorded on the container rather than derived from it. | |
| Abbreviation | BUD |
| Assigned by | The compounder or the person opening the container |
| Basis | Compendial default tables, or product-specific testing |
| Contrast | Expiration date, assigned by the manufacturer from stability data |
| Compendial framework | |
| Sterile compounding | USP <797> |
| Nonsterile compounding | USP <795> |
| Container and storage definitions | USP <659> |
| Stability in dispensing practice | USP <1191> |
| Topic infobox · conventions | |
A beyond-use date (BUD) is the date, or date and time, after which a compounded preparation or an opened container is not to be used. It is assigned by the person who prepares or opens the preparation, using compendial default tables or, where available, testing specific to the preparation. It is distinct from an expiration date, which is assigned by a manufacturer on the basis of a formal stability programme conducted on the finished product in its final container.[1][2]
The distinction is one of evidence rather than of vocabulary. An expiration date rests on long-term, intermediate and accelerated stability studies conducted under the conditions specified in ICH Q1A(R2), analysed statistically, and submitted to a regulator; it is a claim about the specific product in the specific container. A beyond-use date generally rests on a table of conservative defaults chosen to be safe across a wide range of preparations, and it is a claim about a class of preparations rather than about the one in hand. The two are therefore not comparable quantities, and a short beyond-use date does not imply a preparation degrades quickly.[3][1]
Beyond-use dates in sterile compounding are limited principally by microbiological risk rather than by chemical degradation. The default periods in USP <797> are graduated by how the preparation was made, by whether sterility testing was performed and passed, and by storage temperature — not by the chemistry of the active substance. Chemical stability is a separate constraint, and where it is shorter it governs.[1]
The distinction between the two kinds of date is imperfectly maintained in secondary sources and in ordinary usage, where both are called an expiry. On this wiki the conflation has been the subject of a request for comment, and the resulting convention is that expiration date is reserved for manufacturer dating supported by a stability programme, and beyond-use date for everything else.[4]
Definition and contrast with the expiration date
[edit]An expiration date is the output of a defined regulatory process. Under ICH Q1A(R2), a manufacturer conducts long-term studies at the intended storage condition, intermediate studies where required, and accelerated studies at elevated temperature and humidity, on at least three primary batches in the container closure system intended for marketing. The results are evaluated — under ICH Q1E — to establish a retest period or shelf life, and the date is stated on the label. It applies to the unopened product stored as labelled.[3]
A beyond-use date has none of that apparatus behind it. It applies to a preparation that the manufacturer's stability programme never examined: a container that has been opened, a solution that has been diluted, a lyophilised solid that has been reconstituted, or a preparation compounded from components. The chemistry may be identical; the container's history is not.
| !Property | Expiration date | Beyond-use date |
|---|---|---|
| Assigned by | Manufacturer | Compounder or dispenser |
| Evidence base | Product-specific stability programme | Compendial default table, or preparation-specific testing |
| Applies to | Unopened product, stored as labelled | Compounded or opened preparation |
| Principal limiting factor | Chemical and physical degradation | Microbiological risk, then chemical stability |
| Regulatory status | Submitted and approved | Assigned under a compendial standard |
| Typical magnitude | 12–60 months | Hours to 180 days |
Two consequences of the table are worth drawing out. Because the two dates are limited by different things, they respond differently to storage: refrigeration extends a microbiologically limited beyond-use date substantially and generally extends an expiration date not at all, since the expiration date already assumes the labelled condition. And because a beyond-use date is assigned rather than measured, it can be assigned correctly to a preparation that has in fact already degraded, if the degradation route was one the default table does not contemplate.[1][2]
Where both dates apply, the earlier governs. A preparation compounded on a date that would yield a 45-day beyond-use date, from a component whose own expiration date falls in 20 days, has a usable life of 20 days.[5]
Sterile preparations under USP <797>
[edit]USP <797> classifies compounded sterile preparations into categories by the conditions under which they are made, and assigns default beyond-use dates by category, by whether sterility testing was performed, and by storage temperature.
Category 1 preparations are made in an unclassified segregated compounding area and carry the shortest dating. Category 2 preparations are made in a cleanroom suite meeting the chapter's requirements. Category 3 preparations meet additional requirements — including sterility and endotoxin testing and more extensive personnel qualification — and may carry substantially longer dating.
| !Preparation method | Sterility tested and passing | Controlled room temperature | Refrigerated | Frozen |
|---|---|---|---|---|
| Aseptically processed, from sterile components only | No | 4 days | 10 days | 45 days |
| Aseptically processed, one or more nonsterile components | No | 1 day | 4 days | 45 days |
| Aseptically processed | Yes | 30 days | 45 days | 60 days |
| Terminally sterilised | No | 14 days | 28 days | 45 days |
| Terminally sterilised | Yes | 45 days | 60 days | 90 days |
Periods are those tabulated in the 2023 revision of the chapter, which differs from earlier revisions; the earlier low-, medium- and high-risk classification has been replaced by the category scheme.[1]
Three structural features of the table repay attention. Sterility testing buys a large extension — from 4 days to 30 at room temperature for an aseptically processed preparation from sterile components — which reflects that the untested default is a bound on the probability of undetected contamination rather than an estimate of when contamination occurs. Introducing a nonsterile starting component shortens the dating sharply, because the bioburden and endotoxin history of that component is unknown. And frozen storage flattens the differences, because microbial growth is suppressed and the residual limit becomes chemical.[1]
References
- ^ a b c d e f United States Pharmacopeia, General Chapter <797>, "Pharmaceutical Compounding — Sterile Preparations", 2023 revision, including the beyond-use date tables for Category 1, 2 and 3 preparations.
- ^ a b United States Pharmacopeia, General Chapter <1191>, "Stability Considerations in Dispensing Practice" (informational). USP–NF, current revision.
- ^ a b International Council for Harmonisation, Q1A(R2): Stability Testing of New Drug Substances and Products (2003), read with Q1E: Evaluation for Stability Data (2003).
- ^ PeptidePedia community dating-practice tally and the 2026 request for comment on dating terminology (self-reported practice; weak evidence — see Project:Sourcing guidelines).
- ^ United States Pharmacopeia, General Chapter <795>, "Pharmaceutical Compounding — Nonsterile Preparations", 2023 revision.